CellTech Accelerator and Fukuoka Jisho Sign MOU to Advance Taiwan–Japan Biotech Collaboration
Fukuoka, Japan – May 19th, 2025 – Celltech Innovation Venture Studio Co., Ltd. (“CellTech Accelerator”), a leading biotech accelerator based in Taipei, Taiwan, officially revealed its newly signed Memorandum of Understanding (MOU) with Fukuoka Jisho Co., Ltd. (“Fukuoka Jisho”) a key player in Japan’s urban development and innovation ecosystem, during PARKS Demo Day 2025 in Fukuoka, Japan.
The MOU, signed earlier in May and unveiled for the first time at the event, outlines a strategic partnership designed to accelerate cross-border collaboration between Taiwan and Japan in the life sciences and biotech sectors. Under the MOU, the two parties will jointly provide infrastructure support, co-branded initiatives, curated investor and industry connections, and localized business development services.
This partnership marks a significant step in CellTech’s broader efforts to build a bridge between Taiwanese biotech innovation and the Japanese healthcare market, with Fukuoka serving as a key entry point.
About Fukuoka Jisho Co., Ltd.:
Fukuoka Jisho Co., Ltd. is a leading urban developer based in Fukuoka, Japan, committed to making the city a place where big dreams come true. In addition to real estate projects across office, commercial, hotel, and logistics sectors, the company has been driving innovation through startup incubation. Since 2017, it has operated Fukuoka Growth Next, one of Japan’s most prominent startup hubs. In January 2026, it will launch a new life science incubation center with wet labs and shared facilities inside the Kyushu University medical campus to support biotech startups and global collaboration.
For more information, please visit: https://fukuokajisho.com/en/
About CellTech Accelerator:
CellTech Accelerator is the first startup accelerator in Asia solely focused on advancing the cell and gene therapy industry. It supports entrepreneurs in translating cell therapy technologies into practical applications by providing financial support, consulting, and commercialization training services. The company has established an entrepreneurial ecosystem and collaborates with investors and industry partners to drive technology commercialization. Additionally, it offers a comprehensive support system that addresses all aspects of growth for cell and gene therapy ventures.
For more information, please visit: https://genecelltech.com/